BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8145762)

  • 1. An alternative Pit-1 RNA splicing product reveals modular binding and nonmodular transcriptional activities of the POU-specific domain.
    Voss JW; Wilson L; Rhodes SJ; Rosenfeld MG
    Mol Endocrinol; 1993 Dec; 7(12):1551-60. PubMed ID: 8145762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The POU-specific domain of Pit-1 is essential for sequence-specific, high affinity DNA binding and DNA-dependent Pit-1-Pit-1 interactions.
    Ingraham HA; Flynn SE; Voss JW; Albert VR; Kapiloff MS; Wilson L; Rosenfeld MG
    Cell; 1990 Jun; 61(6):1021-33. PubMed ID: 2350782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined pituitary hormone deficiency due to the F135C human Pit-1 (pituitary-specific factor 1) gene mutation: functional and structural correlates.
    Vallette-Kasic S; Pellegrini-Bouiller I; Sampieri F; Gunz G; Diaz A; Radovick S; Enjalbert A; Brue T
    Mol Endocrinol; 2001 Mar; 15(3):411-20. PubMed ID: 11222742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pit-1 binding to specific DNA sites as a monomer or dimer determines gene-specific use of a tyrosine-dependent synergy domain.
    Holloway JM; Szeto DP; Scully KM; Glass CK; Rosenfeld MG
    Genes Dev; 1995 Aug; 9(16):1992-2006. PubMed ID: 7649480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of Pit-1 POU domain bound to DNA as a dimer: unexpected arrangement and flexibility.
    Jacobson EM; Li P; Leon-del-Rio A; Rosenfeld MG; Aggarwal AK
    Genes Dev; 1997 Jan; 11(2):198-212. PubMed ID: 9009203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linker length and composition influence the flexibility of Oct-1 DNA binding.
    van Leeuwen HC; Strating MJ; Rensen M; de Laat W; van der Vliet PC
    EMBO J; 1997 Apr; 16(8):2043-53. PubMed ID: 9155030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression cloning and characterization of PREB (prolactin regulatory element binding), a novel WD motif DNA-binding protein with a capacity to regulate prolactin promoter activity.
    Fliss MS; Hinkle PM; Bancroft C
    Mol Endocrinol; 1999 Apr; 13(4):644-57. PubMed ID: 10194769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The virtuoso of versatility: POU proteins that flex to fit.
    Phillips K; Luisi B
    J Mol Biol; 2000 Oct; 302(5):1023-39. PubMed ID: 11183772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallization and preliminary X-ray analysis of Pit-1 POU domain complexed to a 28 base pair DNA element.
    Jacobson EM; Li P; Rosenfeld MG; Aggarwal AK
    Proteins; 1996 Feb; 24(2):263-5. PubMed ID: 8820493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternatively spliced Pit-1 isoform altered in its ability to trans-activate.
    Morris AE; Kloss B; McChesney RE; Bancroft C; Chasin LA
    Nucleic Acids Res; 1992 Mar; 20(6):1355-61. PubMed ID: 1561093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA.
    Sauter P; Matthias P
    Mol Cell Biol; 1998 Dec; 18(12):7397-409. PubMed ID: 9819426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Segments of the POU domain influence one another's DNA-binding specificity.
    Aurora R; Herr W
    Mol Cell Biol; 1992 Feb; 12(2):455-67. PubMed ID: 1732727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal Oct-2 affinity for an extended DNA site and the effect of GST fusion on site preference.
    Rhee JM; Trieu M; Turner EE
    Arch Biochem Biophys; 2001 Jan; 385(2):397-405. PubMed ID: 11368023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solution structure of the POU-specific DNA-binding domain of Oct-1.
    Dekker N; Cox M; Boelens R; Verrijzer CP; van der Vliet PC; Kaptein R
    Nature; 1993 Apr; 362(6423):852-5. PubMed ID: 8479524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The solution structure of the Oct-1 POU-specific domain reveals a striking similarity to the bacteriophage lambda repressor DNA-binding domain.
    Assa-Munt N; Mortishire-Smith RJ; Aurora R; Herr W; Wright PE
    Cell; 1993 Apr; 73(1):193-205. PubMed ID: 8462099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An alternatively spliced form of Pit-1 represses prolactin gene expression.
    Day RN; Day KH
    Mol Endocrinol; 1994 Mar; 8(3):374-81. PubMed ID: 8015554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thyrotropin (TSH)-releasing hormone-responsive elements in the rat TSH beta gene have distinct biological and nuclear protein-binding properties.
    Shupnik MA; Rosenzweig BA; Friend KE; Mason ME
    Mol Endocrinol; 1992 Jan; 6(1):43-52. PubMed ID: 1738370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pit-1 gene expression in the human pituitary and pituitary adenomas.
    Pellegrini I; Barlier A; Gunz G; Figarella-Branger D; Enjalbert A; Grisoli F; Jaquet P
    J Clin Endocrinol Metab; 1994 Jul; 79(1):189-96. PubMed ID: 8027225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional isoforms of Pit-1 generated by alternative messenger RNA splicing.
    Konzak KE; Moore DD
    Mol Endocrinol; 1992 Feb; 6(2):241-7. PubMed ID: 1569967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo mutational analysis of the DNA binding domain of the tissue-specific transcription factor, Pit-1.
    Liang J; Moye-Rowley S; Maurer RA
    J Biol Chem; 1995 Oct; 270(43):25520-5. PubMed ID: 7592721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.